Category: News

Jun 16, 2020

Environmental Attorney Rachael B. Santana Receives Top Young Lawyer Award from the American Bar Association – Update from Lewis, Longman & Walker, P.A.

West Palm Beach, Fla., June 15, 2020 – Lewis, Longman & Walker West Palm Beach attorney Rachael B. Santana has been recognized by the American Bar Association as one of its “On the Rise – Top 40 Young Lawyers” by exemplifying high achievement, innovation, vision, leadership, and service to the […]

Jun 16, 2020

Recent Federal Developments – Update from Bergeson & Campbell, P.C.

Join Bergeson & Campbell, P.C., The Environmental Law Institute, And George Washington University Milken Institute School Of Public Health For The “TSCA Reform — Four Years Later” Virtual Seminar: From the current impacts of the Toxic Substances Control Act (TSCA) on science policies to challenges faced by industry, Lautenberg Implementation […]

Jun 12, 2020

Biobased Products News and Policy Report – Update from Bergeson & Campbell, P.C.

Federal EPA Announces Request For Comments On ICR For Its P2 Awards Program On June 11, 2020, the U.S. Environmental Protection Agency (EPA) announced that its Pollution Prevention (P2) Awards Program is planning to submit an information collection request (ICR) to the Office of Management and Budget (OMB) for review […]

Jun 10, 2020

Massachusetts Land Use Permitting Under COVID-19 Rules: Emergency Litigation, Executive Orders Affecting Environmental and Real Estate Approvals – Update from McGregor & Legere, P.C.

The COVID-19 pandemic has changed the usual procedures, rules, and regulations for land use permitting. Since March 2020, Massachusetts cities and towns, and legal counsel and clients, have seen new legislation that says how municipalities can accept, review, grant, deny, and enforce their permits. Executive Orders and revisions changing state […]

Jun 10, 2020

Senate Finance Committee Holds Hearing on FDA’s Foreign Drug Manufacturing Inspection Process – Update from Bergeson & Campbell, P.C.

Senate Finance Committee Holds Hearing on FDA’s Foreign Drug Manufacturing Inspection Process On June 2, 2020, the Senate Committee on Finance hosted a full Committee hearing entitled “COVID-19 and Beyond:  Oversight of the FDA’s Foreign Drug Manufacturing Inspection Process.” Witnesses represented the U.S. Food and Drug Administration (FDA), U.S. Government […]